Keywords: s-p/pharmacopeia, cxcr2, antagonist, shows, clinical, activity, ph

S-P/Pharmacopeia's CXCR2 antagonist shows clinical activity in Ph I

Article | 20 March 2006

• Print This

Pharmacopeia, an innovator in the discovery and development of novel small-molecule therapeutics, says that one of the compounds resulting from ...

Enjoying this article? To continue reading you need to login or subscribe.